3 results about "Radical treatment" patented technology

The application discloses a breast-conserving surgery perforator flap intelligent navigation system and method based on CT three-dimensional blood vessel reconstruction and AI dynamic blood flow analysis, and comprises an image processing module. The image processing module generates a perforator blood vessel three-dimensional model with an accuracy of plus or minus 0.1 mm based on high-resolution CT thin-layer scanning data with a layer thickness of less than or equal to 0.625 mm through Mimics software. The application significantly improves the postoperative outcome of patients through multidimensional technology cooperation. In terms of complication control, the incidence of complications in the donor area is reduced from 22% in the traditional method to 3% (a reduction of 86%), and the expansion of trauma caused by perforator variation is avoided. In terms of aesthetic effect, for the breast-conserving surgery of medial quadrant breast cancer, the lateral thoracic artery perforator flap (LTAP) is combined with AI volume compensation. After the surgery, the postoperative breast upper pole depression rate is reduced from 35% to 5%, the BREAST-Q score of the patient is increased from 68 to 89, the requirements of 'tumor radical treatment' and 'functional aesthetics' are fully considered, the postoperative life quality of the patient is greatly improved, and the humanistic concept of modern tumor treatment is met.

The present application provides a kind of cervical cancer radical joint vagina lengthening operation restores vagina mould, solve the problem that existing technology cannot stably and continuously exert medicine or compression deeper wound in vagina to stop bleeding.The present application includes mould body, mould body is hollow cylindrical tube, cylindrical tube includes the support portion of top half-spherical, first through-hole is opened in support portion upper side;Push block is arranged in the cylindrical tube, push block top and semi-permeable membrane form a space, agar block is arranged in the space, second through-hole is opened in push block top, liquid capsule is arranged in push block, and the liquid capsule is connected to agar block by second through-hole;Push block limiting device is arranged on the inner side wall of cylindrical tube.After the technical scheme is used, the present application has the following advantages: the whole support is carried out using mould body, and then the agar block that can be pushed out is accurately positioned to wound, and continuous drug application is carried out to wound.Even if wound bleeds, it can also achieve pressing hemostasis, and accelerate recovery speed.

The application relates to the field of biomedical engineering and particularly discloses hollow virus-like nanoparticles for corneal crosslinking as well as a preparation method and application thereof. In view of problems such as the need to destroy epithelium in traditional crosslinking, ultraviolet toxicity and insufficient penetration of sonodynamic carriers, the following scheme is adopted: ① a CTAB / NaOH micelle is used as a template, a TEOS cyclohexane solution is self-assembled to form virus-like silica particles, a hollow ruthenium-based carrier is obtained through RuCl3 deposition and Na2CO3 etching, and a Ru-TiO2 heterojunction mesoporous shell is formed by coating tetrabutyl titanate; ② the nanoparticles are dispersed into a 0.5-5 mu g / mL suspension and instilled on an eye surface, and 1.0-1.5 MHz, 2-3 W / cm2 pulse ultrasound (duty ratio 50-70%, 10-20 min) is applied. The advantage lies in that the virus-like spike structure realizes non-invasive penetration (fluorescence intensity 106.5 AU, 2.8 times that of a traditional carrier), the hollow heterojunction improves SO4 ‑ yield, the anti-enzymolysis time reaches 8.2+ / -0.3 h (210% of the riboflavin / UVA group), and the postoperative eye surface irritation is 0 (ISO 10993-10). The hollow virus-like nanoparticles are suitable for radical treatment of keratoconus with a corneal thickness greater than 300 mu m.